Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study

Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study

Background Gout is of unknown reason associated with cardiovascular disease. Ultrasound is sensitive for detecting crystal deposition and plasma calprotectin is a sensitive inflammatory marker. This study explores the associations between crystal deposition, inflammation and carotid artery pathology...

Full description

Bibliographic Details
Main Authors:	Silvia Rollefstad, Tore K Kvien, Anne Grete Semb, Hilde Berner Hammer, L Terslev, Lars Fridtjof Karoliussen, Gro Jensen
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-11-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/8/2/e002348.full

Similar Items

Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study
by: Tore K Kvien, et al.
Published: (2023-11-01)

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study
by: Till Uhlig, et al.
Published: (2022-04-01)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
by: Puja Khanna, et al.
Published: (2020-10-01)

Assessment of sensitivity and specificity of ultrasonographic features of gout in intercritical and chronic phases
by: Abeer H Ismaiel, et al.
Published: (2019-01-01)

The relationship between ferritin and urate levels and risk of gout
by: Tahzeeb Fatima, et al.
Published: (2018-08-01)

The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout
by: Shaoling Yang, et al.
Published: (2024-03-01)

Replication of Gout/Urate Concentrations GWAS Susceptibility Loci Associated with Gout in a Han Chinese Population
by: Zhiqiang Li, et al.
Published: (2017-06-01)

Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal study
by: Hilde Berner Hammer, et al.
Published: (2017-10-01)

Treat-to-target (T2T) of serum urate (SUA) in gout: a clinical audit in real-world gout patients
by: C.L. Teh, et al.
Published: (2019-10-01)

Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
by: Lisa K. Stamp, et al.
Published: (2022-06-01)

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
by: Rebekah Wrigley, et al.
Published: (2020-03-01)

Urate-lowering drugs in the treatment of gout: The unknown about the known
by: T. S. Panevin, et al.
Published: (2021-12-01)

Clinical Image: In vivo urate spherulites in a patient with gout
by: Ian Pirker, et al.
Published: (2021-12-01)

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
by: Pang L, et al.
Published: (2023-09-01)

Behavioral Characteristics of Gout Patients and Their Impact on the Results of Urate Lowering Therapy
by: J. Chen, et al.
Published: (2021-04-01)

Dose-response meta-analysis on urate, gout, and the risk for Parkinson’s disease
by: Hongtao Chang, et al.
Published: (2022-11-01)

Prevention of arthritis attacks in the use of urate-lowering therapy in patients with gout
by: M. N. Chikina
Published: (2019-01-01)

Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy
by: M S Eliseev, et al.
Published: (2019-05-01)

Impact of urate-lowering therapy on quality of life indicators in patients with gout
by: M. N. Chikina, et al.
Published: (2021-06-01)

Urate-Lowering Therapy Use among US Adults with Gout and the Relationship between Patients’ Gout Treatment Status and Associated Comorbidities
by: Marcos Ortiz-Uriarte, et al.
Published: (2023-02-01)

Dual-energy CT in gout patients: Do all colour-coded lesions actually represent monosodium urate crystals?
by: Sara Nysom Christiansen, et al.
Published: (2020-09-01)

Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
by: Emily E. Holladay, et al.
Published: (2024-04-01)

Penurunan Kadar Asam Urat Klien Gout Arthritis Dengan Senam Ergonomik
by: Ni Nyoman Sri Ayu Devi, et al.
Published: (2023-12-01)

In vivo study of newly developed albumin-conjugated urate oxidase for gout treatment
by: Jeonghaeng Cho, et al.
Published: (2023-12-01)

Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review
by: Adwoa Dansoa Tabi-Amponsah, et al.
Published: (2023-05-01)

Febuxostat as an effective drug of choice for urate-lowering therapy for gout (case report)
by: A. B. Bashkova, et al.
Published: (2022-08-01)

Uric acid, gout and cardiovascular diseases: prospects for the use of urat-lowering medications
by: M. S. Eliseev, et al.
Published: (2019-08-01)

The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
by: Jackson Robert L, et al.
Published: (2012-03-01)

Gout - asymptomatic hyperuricemia with/without asymptomatic monosodium urate crystal deposition: To be treated or not?
by: Radak-Perović Marija, et al.
Published: (2019-01-01)

A Detailed Analysis of the Association between Urate Deposition and Erosions and Osteophytes in Gout
by: Caroline Pecherstorfer, et al.
Published: (2020-10-01)

Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan
by: Masafumi Kurajoh, et al.
Published: (2024-01-01)

TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter
by: Xin Sun, et al.
Published: (2023-11-01)

A Randomized Pilot Study of DASH Patterned Groceries on Serum Urate in Individuals with Gout
by: Stephen P. Juraschek, et al.
Published: (2021-02-01)

Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout
by: Fu-Shun Yen, et al.
Published: (2020-02-01)

Antihypertensive therapy optimization and endothelial function in patients with gout and chronic urate tubulointerstitial nephritis
by: M V Lebedeva, et al.
Published: (2010-06-01)

Using multiple Mendelian randomization approaches and genetic correlations to understand obesity, urate, and gout
by: Charleen D. Adams, et al.
Published: (2021-09-01)

Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients
by: Zijing Ran, et al.
Published: (2021-09-01)

Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review
by: Iqbal Gill, et al.
Published: (2020-07-01)

Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
by: Mengying Sun, et al.
Published: (2018-05-01)

Development of a patient decision aid for the initiation of urate-lowering therapy in gout patients
by: Matthijs Janssen, et al.
Published: (2022-02-01)